Julien Blouin
Stock Analyst at Goldman Sachs
(1.54)
# 3,517
Out of 5,245 analysts
31
Total ratings
34.78%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by Julien Blouin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NHP National Healthcare Properties | Initiates: Buy | $20 | $14.77 | +35.41% | 1 | May 18, 2026 | |
| UDR UDR, Inc. | Maintains: Sell | $39 → $35 | $38.01 | -7.92% | 4 | Apr 17, 2026 | |
| JAN Janus Living | Initiates: Neutral | $27 | $26.72 | +1.05% | 1 | Apr 14, 2026 | |
| DOC Healthpeak Properties | Initiates: Neutral | $17 | $19.73 | -13.84% | 1 | Jan 9, 2026 | |
| JLL Jones Lang LaSalle | Maintains: Buy | $361 → $407 | $291.69 | +39.53% | 3 | Nov 26, 2025 | |
| CPT Camden Property Trust | Downgrades: Sell | $118 → $106 | $107.47 | -1.37% | 2 | Sep 17, 2025 | |
| AMH American Homes 4 Rent | Downgrades: Neutral | $43 → $37 | $32.27 | +14.66% | 2 | Sep 17, 2025 | |
| CWK Cushman & Wakefield | Maintains: Buy | $18 → $20 | $12.89 | +55.16% | 5 | Aug 13, 2025 | |
| MRP Millrose Properties | Maintains: Buy | $28 → $32 | $27.63 | +14.01% | 2 | May 15, 2025 | |
| INVH Invitation Homes | Maintains: Buy | $39 → $43 | $29.29 | +46.81% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $17 | $14.60 | +16.44% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $165 → $145 | $96.07 | +50.93% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $176 | $131.07 | +34.28% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $318 | $276.70 | +14.93% | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $81 | $66.20 | +22.36% | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $187 | $131.14 | +42.60% | 1 | Sep 4, 2024 |
National Healthcare Properties
May 18, 2026
Initiates: Buy
Price Target: $20
Current: $14.77
Upside: +35.41%
UDR, Inc.
Apr 17, 2026
Maintains: Sell
Price Target: $39 → $35
Current: $38.01
Upside: -7.92%
Janus Living
Apr 14, 2026
Initiates: Neutral
Price Target: $27
Current: $26.72
Upside: +1.05%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $19.73
Upside: -13.84%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361 → $407
Current: $291.69
Upside: +39.53%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118 → $106
Current: $107.47
Upside: -1.37%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43 → $37
Current: $32.27
Upside: +14.66%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $12.89
Upside: +55.16%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28 → $32
Current: $27.63
Upside: +14.01%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39 → $43
Current: $29.29
Upside: +46.81%
Mar 19, 2025
Maintains: Buy
Price Target: $20 → $17
Current: $14.60
Upside: +16.44%
Mar 19, 2025
Maintains: Neutral
Price Target: $165 → $145
Current: $96.07
Upside: +50.93%
Dec 6, 2024
Initiates: Buy
Price Target: $176
Current: $131.07
Upside: +34.28%
Sep 4, 2024
Initiates: Neutral
Price Target: $318
Current: $276.70
Upside: +14.93%
Sep 4, 2024
Initiates: Neutral
Price Target: $81
Current: $66.20
Upside: +22.36%
Sep 4, 2024
Initiates: Buy
Price Target: $187
Current: $131.14
Upside: +42.60%